Thomas R. Kosten MD JH Waggoner Chair and Professor of PowerPoint PPT Presentation

presentation player overlay
1 / 12
About This Presentation
Transcript and Presenter's Notes

Title: Thomas R. Kosten MD JH Waggoner Chair and Professor of


1
From screening into treatment Implementation
solutions for Alcoholism therapy
  • Thomas R. Kosten MD
  • JH Waggoner Chair and Professor of Psychiatry
    Neuroscience
  • Baylor College of Medicine
  • Research Coordinator
  • VA Substance Use Disorders QUERI

2
Purpose of this Program
  • To compare barriers and benefits in PCC for
    treating problem drinking using Brief
    Interventions (BI) and for treating alcoholism
    using naltrexone (NTX).
  • To compare VISNs and facilities in providing BI
    and NTX using 3 care models TIDES, Behavioral
    Health Laboratory (BHL), and the PCC providers
    themselves.

3
Outline of Presentations
  • Kosten introduce BI and NTX for alcohol use
    disorders (AUD).
  • Harris (PERC) very limited use of NTX for AUD in
    VA.
  • Bradley EPRP chart reviews of AUD treatment in
    PCC.
  • Oslin BHL outcomes in providing BI and NTX for
    AUD in PCC.
  • Kirchner implementing TIDES for AUD treatment in
    PCC
  • Daily 2 year implementation of TIDES for
    treating AUD in PCC across VISN 16

4
Stopping drinking is easy,Ive done it hundreds
of times
  • Mark Twain

5
Alcohol Screening on AUDIT-C Q3 FY06 by VISN
(. Target)
6
Rates of Provider Advice (B.I.)
  • Patient Survey (n14,000 screen)
  • In the past year did a VA provider advise you
    to decrease drinking or not drink?
  • National Mean28 (VISN range 20-36)
  • Thus Brief Interventions (BI) done Uncommonly

7
Alcohol Withdrawal Syndrome
  • Signs tremor, blood pressure and pulse elevated,
    adrenergic arousal
  • Symptoms agitation, anxiety, hallucinations
  • Peak at 3 days, Last 7-10 days
  • Seizures Delirium Tremens fatal complication

8
Are medications needed for detox treatment?
  • Obtain breath alcohol level withdrawal occurs
    as level falls and usually not above 100-150 mg
  • Assess level of withdrawal symptoms (CIWA)
  • Level of care needed inpatient, medical setting,
    duration, medical complications, support?
  • Types of medications
  • Setting support needed for medical safety
    adherence

9
Behavioral interventions during withdrawal
treatment Motivational Interventions
  • Brief Motivational Interventions Course
  • INTRAnet www.bmiforsuv.org
  • Over 750 VA staff in Primary Care completed
    course
  • Four course modules
  • Background, MI Basics, Assessment, Feedback
  • Four separate shorter modules available by Dec
    15th.

10
Can medications reduce alcohol relapse? YES!
  • Naltrexone opiate antagonist taken orally or by
    once monthly injection (Vivatrol)
  • Over 25 studies showing clinical and cost
    efficacy over placebo in preventing relapse
  • Pharmacogenetic selection of best candidates
    (family HX good surrogate)
  • Other medications acamprosate, disulfiram,
    topiramate, carbamazepine, also combinations
  • Most effective, if abstinent at medication start

11
Naltrexone and Relapse Rate by Mu Opiate Receptor
Genotype
12
Perhaps it would help if I go over it one more
time.
Write a Comment
User Comments (0)
About PowerShow.com